CID 71301017

(3-alpha,16-alpha)-eburnamenin-14(15h)-one oxime hydrochloride

Structural Information

Molecular Formula
C19H23N3O
SMILES
CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4/C(=N\O)/C2
InChI
InChI=1S/C19H23N3O/c1-2-19-9-5-10-21-11-8-14-13-6-3-4-7-15(13)22(16(12-19)20-23)17(14)18(19)21/h3-4,6-7,18,23H,2,5,8-12H2,1H3/b20-16-/t18-,19+/m1/s1
InChIKey
HPVDZBKXWQJQRP-FVQWEEDQSA-N
Compound name
(NZ)-N-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-ylidene]hydroxylamine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

309.1841 Da
Monoisotopic Mass

3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 310.19138 174.1
[M+Na]+ 332.17332 186.7
[M+NH4]+ 327.21792 185.7
[M+K]+ 348.14726 177.6
[M-H]- 308.17682 177.0
[M+Na-2H]- 330.15877 177.0
[M]+ 309.18355 176.9
[M]- 309.18465 176.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.